 |
 |
|
|
|
| Glyburide |
 |
| Glyburide |
 |
| 10238-21-8 |
 |
Usage: Used to treat type 2 diabetes. As of 2007, is one of the World Health Organization Pharmacopoeia of two oral hypoglycemic agents.
|
 |
MF: C23H28ClN3O5S
MW: 494.00
Packing detail: 25KG drum
Content: 99% Physical Character: White crystalline powder. Melting point 168-173 ℃. Insoluble in water,slightly soluble in ethanol
acetone
chloroform.
Brief introduce:
In 2003, America's most popular hypoglycemic agents.
A recent survey listed in Table Minge benzene urea brain swelling by preventing the onset of improved animal models. Follow-up studyfound that not using glibenclamide compared with patients who have been taking glibenclamide in patients with type 2 diabetes onsetNIH ratio improved.
|
|
|
|
|
|
